May 11, 2022
The Globe and Mail | Vancouver biotech company AbCellera posts record revenue on continued brisk sales of its COVID-19 antibodies
AbCellera Biologics Inc. Q1 2022 results coverage from The Globe and Mail’s Sean Silcoff, with commentary from Antonia Borovina, Equity Research Analyst.
